MyAverix Finance MyAverix Finance

TW · Healthcare

ScinoPharm Taiwan Ltd (1789)

Drug Manufacturers - Specialty & Generic

ScinoPharm Taiwan Ltd (1789) is listed on TW in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 1789

P/E ratio
18.00

ScinoPharm Taiwan Ltd (1789) — FAQ

What is 1789's P/E ratio?

The price-to-earnings (P/E) ratio for ScinoPharm Taiwan Ltd (1789) is 18.00 (data as of 2026-03-23).

Does ScinoPharm Taiwan Ltd pay a dividend?

Dividend yield is not available in the current snapshot for ScinoPharm Taiwan Ltd (1789). Check the MyAverix Finance app for the latest dividend data.

What sector is ScinoPharm Taiwan Ltd in?

ScinoPharm Taiwan Ltd (1789) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 1789 listed on?

1789 is listed on TW.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play